OPKO Health Operating Income 2010-2024 | OPK
OPKO Health Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $-157 |
2022 | $-226 |
2021 | $19 |
2020 | $58 |
2019 | $-274 |
2018 | $-171 |
2017 | $-276 |
2016 | $-97 |
2015 | $-98 |
2014 | $-146 |
2013 | $-80 |
2012 | $-37 |
2011 | $-23 |
2010 | $-11 |
2009 | $-22 |
OPKO Health Quarterly Operating Income (Millions of US $) |
|
---|---|
2024-09-30 | $14 |
2024-06-30 | $-62 |
2024-03-31 | $-71 |
2023-12-31 | $-69 |
2023-09-30 | $-64 |
2023-06-30 | $7 |
2023-03-31 | $-31 |
2022-12-31 | $-55 |
2022-09-30 | $-88 |
2022-06-30 | $-11 |
2022-03-31 | $-72 |
2021-12-31 | $-63 |
2021-09-30 | $38 |
2021-06-30 | $6 |
2021-03-31 | $38 |
2020-12-31 | $49 |
2020-09-30 | $22 |
2020-06-30 | $27 |
2020-03-31 | $-41 |
2019-12-31 | $-112 |
2019-09-30 | $-39 |
2019-06-30 | $-47 |
2019-03-31 | $-75 |
2018-12-31 | $-90 |
2018-09-30 | $-33 |
2018-06-30 | $-5 |
2018-03-31 | $-43 |
2017-12-31 | $-158 |
2017-09-30 | $-48 |
2017-06-30 | $-26 |
2017-03-31 | $-45 |
2016-12-31 | $-74 |
2016-09-30 | $-24 |
2016-06-30 | $28 |
2016-03-31 | $-28 |
2015-12-31 | $-8 |
2015-09-30 | $-8 |
2015-06-30 | $-25 |
2015-03-31 | $-57 |
2014-12-31 | $-32 |
2014-09-30 | $-48 |
2014-06-30 | $-35 |
2014-03-31 | $-30 |
2013-12-31 | $-36 |
2013-09-30 | $-19 |
2013-06-30 | $-18 |
2013-03-31 | $-7 |
2012-12-31 | $-10 |
2012-09-30 | $-9 |
2012-06-30 | $-9 |
2012-03-31 | $-9 |
2011-12-31 | $-8 |
2011-09-30 | $-6 |
2011-06-30 | $-5 |
2011-03-31 | $-4 |
2010-12-31 | $3 |
2010-09-30 | $-4 |
2010-06-30 | $-6 |
2010-03-31 | $-4 |
2009-12-31 | $-2 |
2009-09-30 | $-6 |
2009-06-30 | $-5 |
2009-03-31 | $-9 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $1.065B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $202.293B | 24.68 |
Intuitive Surgical (ISRG) | United States | $195.881B | 102.41 |
Edwards Lifesciences (EW) | United States | $43.763B | 27.79 |
Alcon (ALC) | Switzerland | $43.327B | 28.99 |
IQVIA Holdings (IQV) | United States | $36.875B | 20.32 |
IDEXX Laboratories (IDXX) | United States | $35.573B | 41.89 |
DexCom (DXCM) | United States | $31.642B | 47.65 |
Waters (WAT) | United States | $23.237B | 34.36 |
STERIS (STE) | Ireland | $21.444B | 24.69 |
SONOVA HOLDING (SONVY) | Switzerland | $20.134B | 0.00 |
Hologic (HOLX) | United States | $17.445B | 18.84 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $13.790B | 14.16 |
Sysmex ADR (SSMXY) | Japan | $13.236B | 41.51 |
Globus Medical (GMED) | United States | $11.494B | 29.11 |
Penumbra (PEN) | United States | $9.559B | 93.64 |
Masimo (MASI) | United States | $9.193B | 44.48 |
Teleflex (TFX) | United States | $8.700B | 13.88 |
Glaukos (GKOS) | United States | $7.624B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $5.190B | 0.00 |
Integer Holdings (ITGR) | United States | $4.713B | 26.71 |
Veracyte (VCYT) | United States | $3.417B | 102.54 |
Inari Medical (NARI) | United States | $3.056B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.780B | 16.05 |
TransMedics (TMDX) | United States | $2.423B | 76.82 |
Nihon Kohden (NHNKY) | Japan | $2.410B | 18.31 |
Elekta AB (EKTAY) | Sweden | $2.150B | 19.33 |
Tandem Diabetes Care (TNDM) | United States | $2.120B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
RxSight (RXST) | United States | $1.740B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.425B | 0.00 |
Artivion (AORT) | United States | $1.243B | 82.36 |
Pulse Biosciences (PLSE) | United States | $1.217B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.878B | 14.92 |
Paragon 28 (FNA) | United States | $0.830B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.716B | 0.00 |
IRadimed (IRMD) | United States | $0.693B | 37.48 |
Mesa Laboratories (MLAB) | United States | $0.686B | 16.17 |
AxoGen (AXGN) | United States | $0.653B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.591B | 0.00 |
SiBone (SIBN) | United States | $0.578B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.570B | 0.00 |
Semler Scientific (SMLR) | United States | $0.525B | 30.93 |
Treace Medical Concepts (TMCI) | United States | $0.502B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.456B | 24.70 |
Delcath Systems (DCTH) | United States | $0.365B | 0.00 |
CVRx (CVRX) | United States | $0.359B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.351B | 0.00 |
NeuroPace (NPCE) | United States | $0.334B | 0.00 |
AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
Inogen (INGN) | United States | $0.243B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
Accuray (ARAY) | United States | $0.204B | 0.00 |
Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.181B | 0.00 |
Nevro (NVRO) | United States | $0.155B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.147B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.142B | 15.16 |
Spectral Diagnostics (EDTXF) | Canada | $0.110B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.097B | 0.00 |
LENSAR (LNSR) | United States | $0.089B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.086B | 0.00 |
908 Devices (MASS) | United States | $0.086B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.085B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.081B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.074B | 0.00 |
InspireMD (NSPR) | Israel | $0.074B | 0.00 |
Hyperfine (HYPR) | United States | $0.071B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.052B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.046B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.043B | 0.00 |
Envoy Medical (COCH) | United States | $0.043B | 0.00 |
Spectral AI (MDAI) | United States | $0.040B | 0.00 |
Neuronetics (STIM) | United States | $0.036B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
Precision Optics (POCI) | United States | $0.032B | 0.00 |
DarioHealth (DRIO) | United States | $0.026B | 0.00 |
NexGel (NXGL) | United States | $0.024B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
PAVmed (PAVM) | United States | $0.012B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
Tenon Medical (TNON) | United States | $0.007B | 0.00 |
Nuwellis (NUWE) | United States | $0.006B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
Avinger (AVGR) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |